文献速递临床试验与 GCP基础与转化研究

真实与假电针治疗慢性腰背痛的中枢机制:随机安慰剂对照试验方案

Central mechanisms of real and sham electroacupuncture in the treatment of chronic low back pain: study protocol for a randomized, placebo-controlled clinical trial.
PubMed 文献 · Trials · 2018-12-13

本研究为安慰剂对照、参与者与评估者盲法的机制性试验,拟纳入成人慢性腰背痛患者,随机接受8周共16次真实或假电针治疗。主要疼痛调节指标为时间总和(TS),次要为条件性疼痛调制(CPM);主要心理指标为获益预期。计划100例完成治疗者可检测组间中等效应(d=0.5),检验真实电针降低TS及TS降低介导临床改善的假说。

要点

  • 真实电针可能比假电针更显著降低时间总和(TS),反映上行疼痛易化改善。
  • TS降低(及CPM增加)可能介导第10周腰背痛困扰度改善。
  • 获益预期、疼痛灾难化与自我效能可能调节电针临床反应。

核心结论

  • 真实电针相比假电针可能更大程度降低8次治疗后的时间总和(TS)。
  • 8次治疗后TS降低(次要为CPM增加)可能介导第10周腰背痛困扰度改善。
  • 获益预期、疼痛灾难化与自我效能可能调节电针的临床反应。

研究设计与样本

  • 安慰剂对照、参与者盲法与评估者盲法的机制性随机对照试验。
  • 成人慢性腰背痛患者随机接受8周内共16次真实或假电针治疗。
  • 计划100例完成治疗者,设80%把握度检测组间中等效应(d=0.5)的TS差异。

主要发现

  • 主要疼痛调节指标为时间总和(TS),近似上行疼痛易化。
  • 次要疼痛调节指标为条件性疼痛调制(CPM),代表下行疼痛调节通路。
  • 主要心理指标为获益预期,次要心理指标为疼痛灾难化与疼痛管理自我效能。
  • 主要临床结局为0-100视觉模拟量表腰背痛困扰度,次要为Roland Morris功能障碍问卷及NIH PROMIS相关条目。

关键数值与推荐

  • 主要疼痛调节指标为时间总和(TS)。
  • 次要疼痛调节指标为条件性疼痛调制(CPM)。
  • 主要心理指标为获益预期,次要为疼痛灾难化与自我效能。
  • 主要临床结局为0-100视觉模拟量表腰背痛困扰度。
  • 次要临床结局为Roland Morris功能障碍问卷与NIH PROMIS相关条目。

临床怎么用

  • 为电针治疗慢性腰背痛的中枢疼痛调节与心理机制提供试验依据。
  • 若假说成立,TS与CPM可能作为电针反应的中枢标志物。
  • 心理因素(预期、灾难化、自我效能)可能用于识别电针获益人群。

局限性

  • 研究为试验方案,尚未报告实际结果数据。
  • 样本量基于100例完成治疗者,未报告脱落率与招募可行性。
  • 机制指标为间接近似(TS代表上行易化、CPM代表下行调节)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic low back pain (CLBP) is the most common chronic pain condition and is often resistant to conventional treatments. Acupuncture is a popular alternative for treating CLBP but its mechanisms of action remain poorly understood. Evidence suggests that pain regulatory mechanisms (particularly the ascending and secondarily the descending pain modulatory pathways) and psychological mechanisms (e.g., expectations, pain catastrophizing and self-efficacy) may be involved in the pathogenesis of CLBP and its response to treatments. We will examine these mechanisms in the treatment of CLBP by electroacupuncture (EA). METHODS: We present the aims and methods of a placebo-controlled, participant-blinded and assessor-blinded mechanistic study. Adult patients with CLBP will be randomized to receiving 16 sessions of real (active) or sham (placebo) EA over the course of 8 weeks. The primary pain regulatory measure for which the study was powered is temporal summation (TS), which approximates ascending pain facilitation. Conditioned pain modulation (CPM), representing a descending pain modulatory pathway, will be our secondary pain regulatory measure. The primary psychological measure is expectations of benefit, and the secondary psychological measures are pain catastrophizing and self-efficacy in managing pain. Main clinical outcomes are back pain bothersomeness on a 0-100 visual analog scale (primary), Roland Morris Disability Questionnaire (secondary), and relevant items from the National Institutes of Health (NIH) Patient-Reported Outcome Measures Information System (secondary). We hypothesize that compared to sham, real EA will lead to greater reduction in TS after 8 treatment sessions (4 weeks); and that reduction in TS (and secondarily, increase in CPM) after 8 treatment sessions will mediate reduction in back pain bothersomeness from baseline to week 10 (clinical response) to EA. We also hypothesize that the three psychological factors are moderators of clinical response. With 100 treatment completers, the study is designed to have 80% power to detect a medium-sized between-group effect (d = 0.5) on temporal summation. DISCUSSION: To the best of our knowledge, this is the first appropriately powered, placebo-controlled clinical trial evaluating mechanisms of EA in the treatment of CLBP. TRIAL REGISTRATION: ClinicalTrials.gov, NCT02503475 . Registered on 15 July 15 2015. Retrospectively registered.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kong JT, MacIsaac B, Cogan R, et al. Central mechanisms of real and sham electroacupuncture in the treatment of chronic low back pain: study protocol for a randomized, placebo-controlled clinical trial. Trials. 2018. PMID: 30541586. doi:10.1186/s13063-018-3044-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。